Brits Jump Into Avastin-Lucentis Controversy

The Guardian in the UK reports this morning that its National Health Service will also sponsor a clinical trial comparing Avastin to Lucentis for macular degeneration. Medicare recently changes its rules so that it can financially support a similar National Institutes of Health trial in the U.S. (see this GoozNews).

The movement toward governments sponsoring comparative effectiveness research to lower costs is gathering steam.